LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
11.50
-0.40 (-3.36%)
At close: Aug 11, 2026, 4:00 PM EDT
11.51
+0.01 (0.09%)
After-hours: Aug 11, 2026, 4:00 PM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, LifeStance Health Group stock has a consensus rating of "Buy" and an average price target of $12.9. The average 1-year stock price forecast is 12.17% higher than the current stock price, while the lowest is $9.00 (-21.74%) and the highest is $16 (+39.13%).
Price Target: $12.9 (+12.17%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for LifeStance Health Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $13 | Buy | Reiterates | $13 | +13.04% | Aug 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $13 | Buy | Maintains | $13 | +13.04% | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $10 → $13 | Buy | Reiterates | $10 → $13 | +13.04% | Aug 7, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | +13.04% | Aug 7, 2026 |
| BTIG | BTIG | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +39.13% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
1.69B
from 1.42B
Increased by 18.67%
Revenue Next Year
1.93B
from 1.69B
Increased by 14.35%
EPS This Year
0.42
from 0.18
Increased by 132.01%
EPS Next Year
0.51
from 0.42
Increased by 20.22%
EPS and Forward PE are based on non-GAAP adjusted numbers.